Antengene Corporation Ltd
HKEX:6996
Antengene Corporation Ltd
Total Liabilities
Antengene Corporation Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Antengene Corporation Ltd
HKEX:6996
|
Total Liabilities
¥493.9m
|
CAGR 3-Years
45%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Total Liabilities
¥3B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Total Liabilities
¥4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
19%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Total Liabilities
¥4.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Total Liabilities
¥14.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
11%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Total Liabilities
¥1.9B
|
CAGR 3-Years
97%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Antengene Corporation Ltd
Glance View
Antengene Corp. Ltd. operates as clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
See Also
What is Antengene Corporation Ltd's Total Liabilities?
Total Liabilities
493.9m
CNY
Based on the financial report for Dec 31, 2024, Antengene Corporation Ltd's Total Liabilities amounts to 493.9m CNY.
What is Antengene Corporation Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-18%
Over the last year, the Total Liabilities growth was 5%. The average annual Total Liabilities growth rates for Antengene Corporation Ltd have been 45% over the past three years , -18% over the past five years .
You don't have any saved screeners yet